NCT06309927

Brief Summary

Non-blinded prospective randomized study. 100 women diagnosed with early pregnancy loss up to 10 gestational weeks who opted for surgical management (after being offered the options of conservative management and medical treatment) will be recruited. Qualifying patients will sign an informed consent form and will be randomly assigned to the two arms of the study:

  1. 1.Surgical uterine evacuation by the traditional ultrasound-guided suction curettage (control group)
  2. 2.Surgical uterine evacuation by operative hysteroscopy using a tissue removal device (study group).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
19 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

March 7, 2024

Last Update Submit

January 25, 2026

Conditions

Keywords

hysteroscopycurettageearly pregnancy losstissue removal device

Outcome Measures

Primary Outcomes (3)

  • Operative complications

    Short term surgical complications including estimated blood loss \> 500 ml, fluid deficit \> 2500 ml, uterine perforation, re-admission, fever

    1 week

  • Intrauterine adhesions

    Assessment of intrauterine adhesions by diagnostic office hysteroscopy

    6 weeks

  • Subsequent fertility

    Rates of subsequent pregnancy

    6 months

Secondary Outcomes (1)

  • Conversion from operative hysteroscopy to suction curettage

    1 day

Study Arms (2)

Operative hysteroscopy

EXPERIMENTAL

Surgical evacuation of the uterine cavity by operative hysteroscopy (tissue removal device, Truclear Mini-Elite)

Procedure: Operative hysteroscopy (by tissue removal device)

Suction curettage

ACTIVE COMPARATOR

Surgical evacuation of the uterine cavity by ultrasound guided suction curettage

Procedure: Suction curettage

Interventions

Surgical evacuation of the uterine cavity using the Truclear Mini-Elite hysteroscopic tissue removal device

Operative hysteroscopy

Surgical evacuation of the uterine cavity with electrical vacuum suction curette

Suction curettage

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Early pregnancy loss (miscarriage) up to 10 gestational weeks
  • Able to give informed consent, and read/write in Hebrew

You may not qualify if:

  • Incomplete abortion presenting as heavy vaginal bleeding and dilated cervix
  • Signs of infection and/or suspicion of septic abortion
  • Previous diagnosis of Mullerian anomalies - septate, bicornuate, unicornuate or didelphi uterus
  • Previous medical or surgical treatment in the current pregnancy
  • Previous diagnosis or past surgery for intrauterine adhesions
  • History of 2 or more prvious miscarriages
  • History of 2 or more cesarean sections
  • History of abdominal, vaginal or hysteroscopic myomectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shamir Medical Center

Be’er Ya‘aqov, 70200, Israel

Location

Related Publications (1)

  • 1. Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J, Brosens JJ, Brewin J, Ramhorst R, Lucas ES, McCoy RC, Anderson R, Daher S, Regan L, Al-Memar M, Bourne T, MacIntyre DA, Rai R, Christiansen OB, Sugiura-Ogasawara M, Odendaal J, Devall AJ, Bennett PR, Petrou S, Coomarasamy A. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397:1658-1667. 2. ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss. Obstet Gynecol. 2018;132:1311-1313. 3. Shaker M, Smith A. First Trimester Miscarriage. Obstet Gynecol Clin North Am. 2022;49:623-635. 4. Upadhyay UD, Desai S, Zlidar V, Weitz TA, Grossman D, Anderson P, Taylor D. Incidence of emergency department visits and complications after abortion. Obstet Gynecol. 2015;125:175-183. 5. Paul ME, Mitchell CM, Rogers AJ, Fox MC, Lackie EG. Early surgical abortion: efficacy and safety. Am J Obstet Gynecol. 2002;187:407-11. 6. Hooker A, Fraenk D, Brölmann H, Huirne J. Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review. Eur J Contracept Reprod Health Care. 2016;21:329-35. 7. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome--one century later. Fertil Steril. 2008;89:759-79. 8. Catena U, D'Ippolito S, Campolo F, Dinoi G, Lanzone A, Scambia G. Hysteroembryoscopy and hysteroscopic uterine evacuation of early pregnancy loss: A feasible procedure in selected cases. Facts Views Vis Obgyn. 2022;14:193-197. 9. Young S, Miller CE. Hysteroscopic resection for management of early pregnancy loss: a case report and literature review. F S Rep. 2022;3:163-167. 10. Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014;173:19-22. 11. Barel O, Krakov A, Pansky M, Vaknin Z, Halperin R, Smorgick N. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors? Fertil Steril. 2015;103:775-9. 12. Weinberg S, Pansky M, Burshtein I, Beller U, Goldstein H, Barel O. A Pilot Study of Guided Conservative Hysteroscopic Evacuation of Early Miscarriage. J Minim Invasive Gynecol. 2021;28:1860-1867. 13. Bar-On S, Berkovitz Shperling R, Cohen A, Akdam A, Michaan N, Levin I, Rattan G, Tzur Y. Primary Resectoscopic Treatment of First-Trimester Miscarriage. J Obstet Gynaecol Can. 2023:102327. 14. Huchon C, Drioueche H, Koskas M, Agostini A, Bauville E, Bourdel N, Fernandez H, Fritel X, Graesslin O, Legendre G, Lucot JP, Panel P, Raiffort C, Giraudet G, Bussières L, Fauconnier A. Operative Hysteroscopy vs Vacuum Aspiration for Incomplete Spontaneous Abortion: A Randomized Clinical Trial. JAMA. 2023;329:1197-1205.

    BACKGROUND

MeSH Terms

Conditions

Abortion, SpontaneousGynatresia

Interventions

Vacuum Curettage

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Dilatation and CurettageCurettageSurgical Procedures, OperativeGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Noam Smorgick, MD

    Assaf-Harofeh Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Minimally Invasive Gynecologic Surgery

Study Record Dates

First Submitted

March 7, 2024

First Posted

March 13, 2024

Study Start

April 1, 2024

Primary Completion

March 30, 2025

Study Completion

February 1, 2026

Last Updated

January 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations